Esophagitis: clinical and endoscopic assessment of sucralfate therapy.
Twenty patients with endoscopically proved reflux esophagitis were studied. Each patient was given 1 gm sucralfate 4 times a day for 6 weeks. Clinical and endoscopic assessment of the effects of sucralfate on reflux esophagitis was done. 50% patients became asymptomatic and 60% healed endoscopically. The drug was well tolerated. We conclude that sucralfate is an effective and well tolerated drug for treatment of reflux esophagitis.
Chopra
B K
BK
Department of Medicine Government Medical College/Rajendra Hospital, Patiala.
Kazal
H L
HL
Mittal
P K
PK
Sibia
S S
SS
D000328:Adult; D004942:Esophagitis, Peptic / Q000175:diagnosis / Q000188:drug therapy*; D004945:Esophagoscopy; D006801:Humans; D013392:Sucralfate / Q000009:adverse effects / Q000627:therapeutic use*
D013392:Sucralfate